Companies: 10,795·Total market cap: $144.5T
Artemis Therapeutics Inc.

Artemis Therapeutics Inc.

ATMSOTCFinancial Services
$0.50
$-1.39(-73.65%)
Market Cap$55792932
P/E Ratio—
52W High$4.5
52W Low$0.1121
SEC Filings

Artemis Therapeutics Inc. (ATMS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001062128 · ATMS · OTC · as of Jun 9, 2026

Filing snapshot

454
Total Filings
REVOKED
Latest Form
2026-04-15
Most Recent
1998
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001062128 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-05-03
Fiscal Year End
May 3, 2023
Accession No.
0001178913-23-001679
Primary Document
zk2329636.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001062128 · Accession 0001178913-23-001679

Latest Key Filings

10-QQuarterly Report
QUARTERLY REPORT
2023-11-21
View 10-Q on SEC
8-KCurrent Report
8-K
2023-05-22Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
REVOKEDREVOKED
REVOKED
2026-04-15
View
10-QQuarterly Report
QUARTERLY REPORT
2023-11-21
View
NT 10-QNT 10-Q
NOTIFICATION OF LATE FILING
2023-11-14
View
NT 10-QNT 10-Q
NOTIFICATION OF LATE FILING
2023-08-15
View
10-QQuarterly Report
QUARTERLY REPORT
2023-08-15
View
EFFECTEFFECT
EFFECT
2023-05-26
View
POS AMPOS AM
POS AM
2023-05-23
View
8-KCurrent Report
8-K
2023-05-22
View
10-QQuarterly Report
10-Q
2023-05-18
View
NT 10-QNT 10-Q
NT 10-Q
2023-05-15
View
POS AMPOS AM
POS AM
2023-05-12
View
10-K/AAnnual Report (Amended)
10-K/A
2023-05-03
View
10-K/AAnnual Report (Amended)
20-F
2023-04-06
View
10-KAnnual Report
20-F
2023-03-31
View
EFFECTEFFECT
EFFECT
2023-01-04
View
Showing 1–15 of 368 filingsForm 4 / 144 hidden· 454 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001062128  |  Exchange: OTC · Financial Services

Artemis Therapeutics Inc. (OTC: ATMS) has submitted 454 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1998. As a Financial Services sector company with CIK 0001062128, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Artemis Therapeutics Inc.'s most comprehensive regulatory disclosure. The most recent Artemis Therapeutics Inc. 10-K was filed on 2023-05-03 for fiscal year ending 2023. Historical ATMS 10-K annual reports are available from 1998 through 2023.

Investors researching Artemis Therapeutics Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Financial Services
SLBK SEC Filings →PORT SEC Filings →CLOE SEC Filings →BHAC SEC Filings →PTCP SEC Filings →AOAO SEC Filings →JMTM SEC Filings →KWAC SEC Filings →
→ ATMS Financials→ ATMS Earnings→ ATMS Insider Trades

Frequently Asked Questions

ATMS SEC Filings · 8 questions

Artemis Therapeutics Inc. (ATMS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 454 filings and access original documents at no cost. Artemis Therapeutics Inc.'s CIK is 0001062128.

ATMS SEC filingsArtemis Therapeutics Inc. SEC documentsfind ATMS 10-K